Prof. Nicholas Francis
Safe reduction of antibiotics for acute exacerbations of chronic obstructive pulmonary disease using CRP point-of-care testing: The findings of the PACE Study.
Prof. Rogier Hopstaken
Reduction of antibiotic prescribing at primary care: Evidence of the established role of CRP point-of-care testing.
Join our panel of experts from across Europe to learn about the value of C-reactive protein (CRP) point-of-care testing (POCT) to help fight antimicrobial resistance and as an aid to help avoid the misuse of antibiotics. 90% of respiratory tract infections (RTIs) are viral and therefore antibiotics have no clinical benefit. And yet RTIs are one of the most common reasons for unnecessary antibiotic prescribing . The webinar will analyse studies and present front-line experience on the value of CRP POCT told through the eyes of internationally acclaimed healthcare professionals and academics from the UK, the Netherlands and Italy.
- ↑ CDC. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Update 27. Oct 2020. Downloaded June 2021. https://stacks.cdc.gov/view/cdc/89980
<strong>© 2023 Abbott. All rights reserved.</strong> All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model. Products available in select markets only. COL-00000